FDA recall D-1293-2019

Par Pharmaceutical, Inc. · Class I · drug

Product

Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044

Reason for recall

Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product

Distribution

nationwide

Key facts

Status
Terminated
Initiation date
2019-04-30
Report date
2019-05-15
Termination date
2023-06-20
Voluntary/Mandated
Voluntary: Firm initiated
Location
Chestnut Ridge, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1293-2019